Insulet Posts 3Q EPS of $2.03
PODD sits 23% above its 52-week low of $126.4.
Summary
Insulet reported third-quarter earnings per share of $2.03, with net income of $141.1M and revenue of $842M, which came in above the IBES estimate of USD 832.7 Million. The company raised its FY26 total revenue growth guidance to 21%-22% in constant currency and its adjusted operating margin expansion guidance to ~150 bps year over year. It has authorized a $1B buyback and plans roughly $400M in repurchases in the fourth quarter. That follows earlier balance-sheet moves: repurchasing $218M of stock in Q1 and repricing its $475M term loan 25bps lower in September while upsizing its revolver to $750M.
Updated with an SEC 8-K filing · What changed
Updates
· SEC 8-K — Insulet raised FY26 total revenue growth guidance to 21%-22% in constant currency and adjusted operating margin expansion to ~150 bps year over year.
At the time of this announcement, PODD was trading at $155.77 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $10.7B. The 52-week trading range was $126.40 to $354.88. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.